Search results (318)
« Back to PublicationsMultinational validation of the PREVENT and SCORE2 cardiovascular risk equations across 6.4 million individuals.
Neuen BL. et al, (2026), Nat Med
Positive Predictive Value of Respiratory Infection Diagnoses in The Danish National Patient Registry: a Post-hoc Validation Analysis of the DANFLU-1 Trial.
Christensen J. et al, (2026), Int J Infect Dis
Effects of Empagliflozin on Urine Biomarkers in EMPA-KIDNEY.
Malijan GB. et al, (2026), Am J Kidney Dis, 87, 553 - 563.e1
Relative Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccination Against Hospitalizations and Deaths According to Frailty Score: A Post Hoc Analysis of the DANFLU-1 Randomized Trial.
Espersen C. et al, (2026), J Infect Dis, 233, e89 - e98
Relative effectiveness of high-dose versus standard-dose influenza vaccine against hospitalizations and mortality according to Charlson Comorbidity Index: A post-hoc analysis of the DANFLU-1 randomized trial
Feldballe Bernholm K. et al, (2026), European Journal of Clinical Microbiology and Infectious Diseases
A pragmatic individually randomized trial to evaluate the effectiveness of high-dose vs standard-dose influenza vaccine in older adults: Rationale and design of the DANFLU-2 trial.
Johansen ND. et al, (2026), Am Heart J, 291, 186 - 198
Characteristics of interventional clinical trials registered in ClinicalTrials.gov, 2018-2023.
Sullenger RD. et al, (2026), J Clin Transl Sci, 10
High-Dose vs Standard-Dose Influenza Vaccine in Chronic Kidney Disease: The DANFLU-2 Trial Subgroup Analysis.
Bartholdy KV. et al, (2025), J Am Coll Cardiol, 86, 2636 - 2647
High-Dose Influenza Vaccine Effectiveness against Hospitalization in Older Adults.
Johansen ND. et al, (2025), N Engl J Med, 393, 2291 - 2302
Discordance in Creatinine- and Cystatin C-Based eGFR and Clinical Outcomes: A Meta-Analysis.
Estrella MM. et al, (2025), JAMA, 334, 1915 - 1926
Effectiveness of High-Dose vs. Standard-Dose Influenza Vaccine in Older Adults with Diabetes: The DANFLU-2 Randomized Clinical Trial
Nielsen AB. et al, (2025), JAMA Internal Medicine
High-dose vs. standard-dose inactivated influenza vaccine and cardiovascular outcomes in persons with or without pre-existing atherosclerotic cardiovascular disease: the DANFLU-2 trial.
Pareek M. et al, (2025), Eur Heart J, 46, 4282 - 4290
Effects Of Empagliflozin On Kidney And Cardiac Magnetic Resonance Imaging Measures In Patients With Chronic Kidney Disease: An EMPA-KIDNEY Mechanistic Substudy
ZHU D. et al, (2025), American Journal of Kidney Diseases